Publikation: Programmed neurite degeneration in human central nervous system neurons driven by changes in NAD+ metabolism
Dateien
Datum
Herausgeber:innen
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
URI (zitierfähiger Link)
DOI (zitierfähiger Link)
Internationale Patentnummer
Link zur Lizenz
Angaben zur Forschungsförderung
Institutionen der Bundesrepublik Deutschland: 161L0243B
Institutionen der Bundesrepublik Deutschland: 016LW0146K
European Union (EU): 964537
European Union (EU): 964518
European Union (EU): 101057014
Projekt
Open Access-Veröffentlichung
Sammlungen
Core Facility der Universität Konstanz
Titel in einer weiteren Sprache
Publikationstyp
Publikationsstatus
Erschienen in
Zusammenfassung
Neurite degeneration (ND) precedes cell death in many neurodegenerative diseases. However, it remains unclear how this compartmentalized cell death process is orchestrated in the central nervous system (CNS). The establishment of a CNS axotomy model (using modified 3D LUHMES cultures) allowed us to study metabolic control of ND in human midbrain-derived neurons without the use of toxicants or other direct disturbance of cellular metabolism. Axotomy lead to a loss of the NAD+ synthesis enzyme NMNAT2 within 2 h and a depletion of NAD+ within 4-6 h. This process appeared specific, as isolated neurites maintained ATP levels and a coupled mitochondrial respiration for at least 6 h. In the peripheral nervous system (PNS) many studies observed that NAD+ metabolism, in particular by the NADase SARM1, plays a major role in the ND occurring after axotomy. Since neither ferroptosis nor necroptosis, nor caspase-dependent apoptosis seemed to be involved in neurite loss, we investigated SARM1 as potential executioner (or controller). Knock-down or expression of a dominant-negative isoform of SARM1 indeed drastically delayed ND. Various modifications of NAD+ metabolism known to modulate SARM1 activity showed the corresponding effects on ND. Moreover, supplementation with NAD+ attenuated ND. As a third approach to investigate the role of altered NAD+ metabolism, we made use of the WLD(s) protein, which has been found in a mutant mouse to inhibit Wallerian degeneration of axons. This protein, which has a stable NMNAT activity, and thus can buffer the loss of NMNAT2, protected the neurites by stabilizing neurite NAD+ levels. Thus CNS-type ND was tightly linked to neurite metabolism in multiple experimental setups. Based on this knowledge, several new strategies for treating neurodegenerative diseases can be envisaged.
Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
Schlagwörter
Konferenz
Rezension
Zitieren
ISO 690
BRÜLL, Markus, Selina MULTRUS, Michael SCHÄFER, Ivana CELARDO, Christiaan KARREMAN, Marcel LEIST, 2025. Programmed neurite degeneration in human central nervous system neurons driven by changes in NAD+ metabolism. In: Cell Death & Disease. Springer. 2025, 16(1), 24. eISSN 2041-4889. Verfügbar unter: doi: 10.1038/s41419-024-07326-wBibTex
@article{Brull2025-01-17Progr-72010, title={Programmed neurite degeneration in human central nervous system neurons driven by changes in NAD<sup>+</sup> metabolism}, year={2025}, doi={10.1038/s41419-024-07326-w}, number={1}, volume={16}, journal={Cell Death & Disease}, author={Brüll, Markus and Multrus, Selina and Schäfer, Michael and Celardo, Ivana and Karreman, Christiaan and Leist, Marcel}, note={Article Number: 24} }
RDF
<rdf:RDF xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:void="http://rdfs.org/ns/void#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/72010"> <dc:creator>Leist, Marcel</dc:creator> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <dcterms:issued>2025-01-17</dcterms:issued> <dc:contributor>Karreman, Christiaan</dc:contributor> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2025-01-22T11:50:22Z</dc:date> <dc:creator>Karreman, Christiaan</dc:creator> <dcterms:abstract>Neurite degeneration (ND) precedes cell death in many neurodegenerative diseases. However, it remains unclear how this compartmentalized cell death process is orchestrated in the central nervous system (CNS). The establishment of a CNS axotomy model (using modified 3D LUHMES cultures) allowed us to study metabolic control of ND in human midbrain-derived neurons without the use of toxicants or other direct disturbance of cellular metabolism. Axotomy lead to a loss of the NAD<sup>+</sup> synthesis enzyme NMNAT2 within 2 h and a depletion of NAD<sup>+</sup> within 4-6 h. This process appeared specific, as isolated neurites maintained ATP levels and a coupled mitochondrial respiration for at least 6 h. In the peripheral nervous system (PNS) many studies observed that NAD<sup>+</sup> metabolism, in particular by the NADase SARM1, plays a major role in the ND occurring after axotomy. Since neither ferroptosis nor necroptosis, nor caspase-dependent apoptosis seemed to be involved in neurite loss, we investigated SARM1 as potential executioner (or controller). Knock-down or expression of a dominant-negative isoform of SARM1 indeed drastically delayed ND. Various modifications of NAD<sup>+</sup> metabolism known to modulate SARM1 activity showed the corresponding effects on ND. Moreover, supplementation with NAD<sup>+</sup> attenuated ND. As a third approach to investigate the role of altered NAD<sup>+</sup> metabolism, we made use of the WLD(s) protein, which has been found in a mutant mouse to inhibit Wallerian degeneration of axons. This protein, which has a stable NMNAT activity, and thus can buffer the loss of NMNAT2, protected the neurites by stabilizing neurite NAD<sup>+</sup> levels. Thus CNS-type ND was tightly linked to neurite metabolism in multiple experimental setups. Based on this knowledge, several new strategies for treating neurodegenerative diseases can be envisaged.</dcterms:abstract> <dc:contributor>Brüll, Markus</dc:contributor> <dcterms:title>Programmed neurite degeneration in human central nervous system neurons driven by changes in NAD<sup>+</sup> metabolism</dcterms:title> <foaf:homepage rdf:resource="http://localhost:8080/"/> <dc:language>eng</dc:language> <dc:contributor>Celardo, Ivana</dc:contributor> <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/72010/4/Bruell_2-1oj23hpgyshkn2.pdf"/> <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2025-01-22T11:50:22Z</dcterms:available> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <dc:rights>Attribution 4.0 International</dc:rights> <dc:creator>Schäfer, Michael</dc:creator> <dcterms:rights rdf:resource="http://creativecommons.org/licenses/by/4.0/"/> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> <dc:contributor>Multrus, Selina</dc:contributor> <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/72010"/> <dc:creator>Celardo, Ivana</dc:creator> <dc:creator>Brüll, Markus</dc:creator> <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/72010/4/Bruell_2-1oj23hpgyshkn2.pdf"/> <dc:contributor>Schäfer, Michael</dc:contributor> <dc:contributor>Leist, Marcel</dc:contributor> <dc:creator>Multrus, Selina</dc:creator> </rdf:Description> </rdf:RDF>